CeriBell, Inc. Shareholders' Equity
CeriBell, Inc. (CBLL) had Shareholders' Equity of $128.31 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $128.31M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $140.81M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $155.34M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $164.08M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $128.31M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $140.81M 10-Q · filed 2026-08-10 |
| 2025-12-31 | $155.34M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $164.08M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $172.16M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $180.88M 10-Q · filed 2026-08-10 |
| 2024-12-31 | $191.16M 10-Q · filed 2026-08-10 |
| 2024-09-30 | -$135.98M 10-Q · filed 2025-11-04 |
| 2024-06-30 | -$127.28M 10-Q · filed 2025-11-04 |
| 2024-03-31 | -$119.90M 10-Q · filed 2025-11-04 |
| 2023-12-31 | -$112.25M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$105.01M 10-Q · filed 2024-11-12 |
| 2023-06-30 | -$98.66M 10-Q · filed 2024-11-12 |
| 2023-03-31 | -$93.23M 10-Q · filed 2024-11-12 |
| 2022-12-31 | -$86.40M 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |